XRCC2 and breast carcinoma: In addition, we analyzed clinical characteristics of breast cancers in carriers of a XRCC2 mutation, and performed loss of heterozygosity (LOH) analysis at the XRCC2 locus in tumors from XRCC2 mutation-positive women.